Historical record - last NADAC publication: 2/19/2014
Product Information
ANTARA 130 MG CAPSULE is a brand product labeled by Lupin Pharmaceuticals Inc., priced at $6.2148 per EA under NDC 27437011006. Its NADAC has been published 68 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the FENOFIBRATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
130 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
27437011006
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2014
Active Ingredients
FENOFIBRATEApproval Type
New Drug (NDA)
FDA Application
NDA021695On Market Since
9/25/2009
Pharmacological Classes
Price Statistics
The NADAC for ANTARA 130 MG CAPSULE has been published 68 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2148 per EA |
|---|---|
| All-time high | $6.2321 (Feb 12, 2014) |
| All-time low | $6.2148 (Feb 19, 2014) |
| Median price | $6.2148 |
| Average price | $6.2179 |
| Largest weekly change | -0.3% (Feb 19, 2014) |
| Weeks tracked | 68 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FENOFIBRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ANTARA 130 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ANTARA 130 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $6.2148 per EA (NDC 27437011006), effective Mar 11, 2015.
How has the price of ANTARA 130 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ANTARA 130 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ANTARA 130 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ANTARA 130 MG CAPSULE has ranged from a low of $6.2148 (Feb 19, 2014) to a high of $6.2321 (Feb 12, 2014), with a median of $6.2148 per EA.
Are there cheaper alternatives to ANTARA 130 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ANTARA 130 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures ANTARA 130 MG CAPSULE?
ANTARA 130 MG CAPSULE (NDC 27437011006) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification